TranquilMed
Provo · Founded 2010
About TranquilMed
We have a new treatment for those suffering with Restless Legs Syndrome (RLS). 30 million people in the U.S. suffer discomfort and sleep loss due to Restless Legs Syndrome (RLS). Sufferers spend $1.5B for relatively ineffective treatments that produce side effects of nausea and vomiting. These treatments lose effectiveness over time and can make the condition worse. TranquilMed’s new product RestEasy™ is the first treatment with no side effects available to RLS sufferers. We have conducted studies at BYU that show 52% reduction in RLS symptoms in only 12 treatments. These studies have been accepted for publication in peer reviewed medical journals.
Company Facts
- Founded: 2010
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $27.0K
- Last round: Grant (Apr 2010)
- Website: tranquilmed.com
- Phone: 702-332-5369
Social Profiles
Canonical: https://fsome.com/organization/tranquilmed-8421537 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.